Léonore Diezi

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


12 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 |
 
Pharmacovigilance. Sevrage et effet rebond: pas seulement avec les psychotropes [Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs]
Marouf R., Chtioui H., Girardin F.R., Buclin T., Diezi L., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 96-101. Peer-reviewed.
Pregnancy outcomes after GLP-1 agonist exposure in early pregnancy
Winterfeld Ursula, Dao Kim, Haefliger David, Diezi Léonore, Girardin François, 2023/11/23. Swissmedic Vigilance News. Peer-reviewed.
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.
Diezi L., Dao K., Jullien V., Roussel-Maupetit C., Burton I., André P., Bardinet C., Rothuizen L.E., Chtioui H., Manso-Silvan M.A. et al., 2023/02. Pharmacology research & perspectives, 11 (1) pp. e01032. Peer-reviewed.
 
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
André P., Diezi L., Dao K., Crisinel P.A., Rothuizen L.E., Chtioui H., Decosterd L.A., Diezi M., Asner S., Buclin T., 2022. Frontiers in pediatrics, 9 p. 768438. Peer-reviewed.
 
Safety, tolerability and pharmacokinetic profile of Macozinone (PBTZ169) formulated as native crystal powder: multiple ascendingdoses, phase-Ib trial in healthy volunteers
Chtioui H., Prod'Hom S., Desfontaine V., André P., Moulfi F., Bardinet C., Abo-Loha C., Tessieras J., Rothuizen L.E., Diezi L. et al., 2022. dans 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) - June 2022 Athens. European Journal of Clinical Pharmacology, 2022, 78: 1-163.
 
Tests thérapeutiques « N-of-1 » : vers une médecine personnalisée et fondée sur les preuves
Buclin T., Diezi L., 2021/08. Revue Prescrire, 41 (454) pp. 633-635.
 
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Chehade H., Cachat F., Beck-Popovic M., Rotman S., Diezi L., Albisetti M., Alberio L., Young G., Rizzi M., 2020/11. Pediatrics, 146 (5) pp. e20200123. Peer-reviewed.
 
N-of-1 trials ou essais thérapeutiques individuels : un test probant pour diagnostiquer l’efficacité thérapeutique [N-of-1 trials or single-patient therapeutic tests: evidence-based tests to diagnose therapeutic efficacy]
Diezi L., Buclin T., 2019/11/06. Revue medicale suisse, 15 (670) pp. 2058-2061. Peer-reviewed.
 
Automédication et douleur
Buclin Thierry, Diezi Léonore, Monney Aurélia, 2019/05. La Gazette médicale.
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
 
Pharmacovigilance [Pharmacovigilance update].
Fogarasi Szabo N., Diezi L., Delenclos L., Renard D., Chtioui H., Rothuizen L.E., Buclin T., Livio F., 2015/01. Revue Médicale Suisse, 11 (456-457) pp. 124-128.
 
Pharmacovigilance [Pharmacovigilance update].
Diezi L., Renard D., Rothuizen L.E., Livio F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 119-122.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University